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Abstract
Objective To assess interobserver reproducibility of different regions of interest (ROIs) on multi-parametric renal MRI 
using commercially available software.
Materials and methods Healthy volunteers (HV), patients with heart failure (HF) and renal transplant recipients (Tx) were 
recruited. Localiser scans, T1 mapping and pseudo-continuous arterial spin labelling (pCASL) were performed. HV and Tx 
also underwent diffusion-weighted imaging to allow calculation of apparent diffusion coefficient (ADC). For T1, pCASL 
and ADC, ROIs were drawn for whole kidney (WK), cortex (Cx), user-defined representative cortex (rep-Cx) and medulla. 
Intraclass correlation coefficient (ICC) and coefficient of variation (CoV) were assessed.
Results Forty participants were included (10 HV, 10 HF and 20 Tx). The ICC for renal volume was 0.97 and CoV 6.5%. 
For T1 and ADC, WK, Cx, and rep-Cx were highly reproducible with ICC ≥ 0.76 and CoV < 5%. However, cortical pCASL 
results were more variable (ICC > 0.86, but CoV up to 14.2%). While reproducible, WK values were derived from a wide 
spread of data (ROI standard deviation 17% to 55% of the mean value for ADC and pCASL, respectively). Renal volume 
differed between groups (p < 0.001), while mean cortical T1 values were greater in Tx compared to HV (p = 0.009) and HF 
(p = 0.02). Medullary T1 values were also higher in Tx than HV (p = 0.03), while medullary pCASL values were significantly 
lower in Tx compared to HV and HF (p = 0.03 for both).
Discussion Kidney volume calculated by manually contouring a localiser scan was highly reproducible between observers 
and detected significant differences across patient groups. For T1, pCASL and ADC, Cx and rep-Cx ROIs are generally 
reproducible with advantages over WK values.
Keywords Renal MRI · Reproducibility · Chronic kidney disease · Renal transplantation · Heart failure
Introduction
Functional renal imaging is a burgeoning field of research 
that has the potential to translate into meaningful clini-
cal applications for patients with kidney disease [1]. 
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Multi-parametric magnetic resonance imaging (MRI) allows 
acquisition of multiple sequences with potential to inform 
regarding structure, tissue composition, perfusion, and phys-
iology of renal function in a single scan [2]. However, the 
clinical utility of each sequence, and indeed the potential 
additive benefit of their use together, are yet to be proven. 
The immediate research priority in renal MRI is focusing on 
the standardisation and harmonisation of image acquisition 
across research sites and MRI vendors. This ‘ground-up’ 
approach is driven by international, independently funded 
working groups, including PARENCHIMA [2], a subsidi-
ary of the European Cooperation in Science and Technol-
ogy (COST) Action group and the UK Renal Imaging Net-
work (UKRIN), amongst others. As image acquisition is 
standardised, scientific scrutiny must also be applied to the 
methods of analysis. Many of the MRI sequences employed 
produce quantitative results from modelling dependent on 
measurements using other sequences [3], and for which the 
resultant values will vary depending on whether whole kid-
ney, renal cortex or renal medulla is selected [4]. Numer-
ous analytic approaches have been reported to date, and the 
optimal technique in terms of time and clinical relevance, 
are not yet known. In addition, the absence of commercially 
available analysis software that is specifically designed 
for unique interests of renal MRI leads to use of in-house 
bespoke software, which renders external validation of 
results challenging.
Our centre has an active renal MRI research group, 
with current projects exploring the clinical implications of 
multi-parametric renal MRI across healthy volunteers [5] 
as well as patients with heart failure, chronic kidney dis-
ease (CKD) [6] and renal transplants. We aim to compare 
different regions of interest (ROIs) and their interobserver 
reproducibility using commercially available analysis soft-
ware in healthy and patient populations, including native and 
transplant kidneys, across selected MRI sequences.
Methods
Study population and clinical parameters
Patients were recruited from nephrology and cardiology 
clinics, and from general advertisement, for the renal trans-
plant (Tx), heart failure (HF) and healthy volunteer (HV) 
cohorts, respectively. For Tx and HF patients, the scans 
were acquired as baseline imaging for two separate ongo-
ing clinical studies (ClinicalTrials.gov: NCT03705091 and 
NCT03485092). Basic biometric parameters were measured 
and serum creatinine was measured in accredited clinical 
biochemical laboratories. Estimated glomerular filtration 
rate (eGFR) was derived using the Chronic Kidney Disease 
Epidemiology Collaboration (CKD-EPI) equation [7]. All 
participants gave written informed consent and regional 
ethics committee approval was granted; the study was con-
ducted in agreement with the Declaration of Helsinki.
MRI acquisition
MRI was performed on a Siemens MAGNETOM Prisma 
3T scanner (Siemens Healthcare, Erlangen, Germany) using 
an 18-channel phased array coil anteriorly and a 32-channel 
spine coil posteriorly. Scans for renal volume, perfusion and 
T1 were acquired from all patients (Fig. 1), with the trans-
plant kidney scanned for the Tx group. Diffusion-weighted 
imaging (DWI) was performed on the Tx and HV cohorts. 
Patients were imaged supine.
• Volume Coronal images were acquired during a breath 
hold at expiration using a steady-state free precession 
sequence [true fast imaging with steady-state precession 
(TrueFISP)]. The imaging parameters used are listed in 
Supplementary Material Table 1 (HV and Tx cohorts) 
and Supplementary Material Table 2 (HF cohort).
• T1 T1 maps were acquired for a single coronal oblique 
slice through the centre of the kidney using a modified 
look-locker inversion recovery (MOLLI) [8, 9] sequence 
with single shot TrueFISP readout [10]. For Tx and HV 
cohorts, images were acquired at 14 different inversion 
times (TI) [acquisition scheme 11(3)3] with an initial 
delay of 180 ms after the first inversion pulse and a delay 
of 260 ms, after the second inversion pulse. The interval 
between subsequent measurements was 550 ms, resulting 
in TIs of 180, 260, 730, 810, 1280, 1360, 1830, 2380, 
2930, 3480, 4030, 4580, 5130, 5680 ms) and echo spac-
ing of 3.04 ms. The acquisition time was 10 s. Images 
were acquired during free breathing.
  For the HF cohort, images were acquired at eight dif-
ferent inversion times [acquisition scheme 5(3)3] with a 
start TI of 100 ms, a TI increment of 80 ms (inversion 
times dependent on captured cardiac cycle), a reported 
TR of 280–340  ms, and echo spacing of 2.44  ms. 
Images were acquired during a breath hold. Other imag-
ing parameters are given in Supplementary Materials 
Tables 1, 2.
  Motion correction and fitting of the T1 map was per-
formed using a phase-sensitive inversion recovery recon-
struction implemented in the vendor software (Siemens, 
VE11C, MyoMaps) [11].
• Arterial spin labelling A pseudo-continuous arterial spin 
labelling (pCASL) scan [12] with a 3D turbo gradient 
spin-echo (TGSE) readout which was acquired during 
free breathing [13]. The prototype sequence comprises 
a slice-selective presaturation pulse to suppress the sig-
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Fig. 1  Representative image of each MRI sequence for each participant group
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nal from preceding excitations and a frequency-offset-
corrected inversion (FOCI) pulse positioned over the 
imaging region. This is followed by the pCASL slice-
selective labelling pulse. For background saturation, 
four non-selective hyperbolic secant pulses are applied, 
interspersed with three slice-selective saturation pulses, 
positioned superior to the labelling plane.
  The pCASL labelling plane was positioned in a trans-
verse oblique slice of thickness 10 mm perpendicular to 
the aorta and superior to the kidneys to label the blood 
in the descending aorta (Supplementary Material Fig. 1). 
The start time of the pCASL labelling was 3000 ms and 
the pCASL duration was 1500 ms with a flip angle of 28°. 
The presaturation pulses and FOCI pulse were positioned 
in a transverse slab covering the kidneys. The pulses to 
suppress inflowing arterial blood were applied in a slab 
superior to the labelling plane to suppress inflowing arte-
rial blood. Images were obtained in a coronal oblique ori-
entation covering the whole kidney volume. A low-reso-
lution pCASL scan with one measurement was acquired 
to confirm that the positioning of the labelling plane was 
appropriate to produce signal in the perfusion-weighted 
image. This was followed by a higher resolution scan 
with parameters as given in Tables 1, 2. The sequence 
acquires label and control images and a reference proton 
density-weighted (M0) image.
  Perfusion maps were produced using inline software. 
In-plane 2D motion correction is applied, retrospec-
tively, to proton density-weighted (M0) label and control 
images. Label and control images are subtracted to create 
perfusion-weighted images. Maps of perfusion rate (f) 
are calculated pixel by pixel using the motion-corrected 
proton density-weighted (M0) and perfusion-weighted 
(ΔM) images according to:
where f is the perfusion rate in ml/100 mg/min; t is the 
time between labelling and imaging (3000 ms); τ is the 
duration of labelling pulse (1500 ms); Δt is the arterial 
transit time, assumed to be 750 ms; α is the labelling 
efficiency, assumed to be 0.98; λ is the blood-tissue water 
partition coefficient, assumed to be 0.9 ml/100 g; T1blood 
is the longitudinal relaxation time of arterial blood; T1′ 
is the apparent longitudinal relaxation time of tissue. A 
fixed T1blood = T1′ = 1250 ms was assumed in calculating 
the perfusion maps.
• DWI For the Tx and HV cohorts, DWI was performed 
using a single-shot spin-echo echo-planar imag-
ing sequence with 17 slices positioned in a coronal 
ΔM = f
2M0
휆
T1�훼 exp
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−Δt
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)
exp
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T1�
)(
1 − exp
(
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,
oblique plane. Images were acquired at 10 b values 
(0, 50, 100, 150, 200, 250, 300, 500, 750, 1000 s/
mm2) for four diffusion directions, averaged to give a 
4-scan trace. Spectral attenuated inversion recovery 
(SPAIR) fat suppression was used and images were 
acquired during free breathing, with an acquisition 
time of 1 min 46 s. Apparent diffusion coefficient 
(ADC) maps were created using the vendor software, 
performing a mono-exponential fit to the ten b-values 
[14].
MRI analysis
Interobserver variability was compared across different 
methods of image analysis. For kidney volume, the renal 
contours were drawn around the whole kidney (excluding 
the renal pelvis) on the first and last slices containing renal 
tissue. Contours were then added to every alternate slice in 
between. This initial total kidney volume (linear interpola-
tion for non-contoured slices) was then recorded (‘alternate 
slices’) prior to drawing contours to the remaining slices 
and noting the resultant volume (‘every slice’). For pCASL 
and DWI, a single slice was chosen for analysis. ROIs were 
drawn manually around the whole kidney (WK), cortex 
(Cx), an area of user-defined representative cortex (rep-Cx), 
within the cortex at the superior and inferior poles (sup-
Cx and inf-Cx, respectively) and in a representative area 
of medulla (Med) (Fig. 2). Corticomedullary differentiation 
was assessed by ratio of Cx to Med. Each cohort was ana-
lysed by a pair of independent observers from a pool of four 
clinicians and one physicist, all with local training in renal 
MRI analysis (SAS and LZ analysed HV, SAS and MMYL 
analysed HF and KAG and AJR analysed Tx). Image analy-
sis was performed using the commercially available software 
cvi42 version 5.9.4 (Circle Cardiovascular Imaging, Calgary, 
Canada).
Statistical analysis
Descriptive statistics are reported as mean and standard 
deviation or median and range/interquartile range (IQR) for 
normally distributed and skewed data, respectively. Paired 
t-tests were used to compare kidney volume techniques and 
results were displayed graphically using a Bland–Altman 
plot [15]. Pearson correlation coefficient was used to quan-
tify linear relationships between continuous variables. A 
total of 12 participants are required to detect a correlation 
coefficient of 0.8 with 90% power and alpha 0.05. Our deci-
sion to include 40 participants yields a power > 99.9% to 
detect a correlation coefficient of 0.8 at alpha 0.05. Interob-
server reproducibility was measured using coefficient of var-
iation (CoV) (calculated by the standard deviation divided 
by the mean) and intraclass correlation coefficient (ICC) 
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(two-way random, average measures). One-way ANOVA 
was used to compare mean results across the three partici-
pant groups, with t-tests to interrogate pairs where groups 
differed. The mean value of the two observers is reported 
unless otherwise stated. All analyses were performed using 
SPSS Statistics Version 25.0 (Armonk, NY: IBM Corp.) and 
a conventional significance level of < 0.05 was used. Figures 
were generated using SPSS Statistics Version 25.0 (Armonk, 
NY: IBM Corp.) and Microsoft  PowerPoint® 2019.
Results
Participant demographics
A total of 40 participants were included: ten healthy volun-
teers, ten patients with heart failure (with reduced ejection 
fraction of ≤ 40%) and 20 renal transplant recipients. Clinical 
characteristics are shown in Table 1.
Renal volume
Calculation of renal volume was possible in 39 patients 
(98%) (one patient did not have appropriate TrueFISP 
images). Mean difference in renal volume was 1.6 ml lower 
when contours were drawn on alternate slices as opposed 
to every slice (p < 0.001) (Fig. 3). There was no inter-
observer difference in renal volume with either approach 
(p = 0.56 for alternate slice, and p = 0.89 for every slice). 
Tables 2, 3 show the results and interobserver reproduc-
ibility for renal volume, respectively.
T1, pCASL, ADC: comparison of different ROIs
T1, pCASL and ADC sequences were acquired in 39, 39 
and 28 patients, respectively. Image quality was acceptable 
in all but two pCASL acquisitions in the Tx group who were 
excluded from further analysis. Table 2 shows the mean 
results for each sequence depending on whether ROIs were 
drawn for WK, Cx, rep-Cx, sup-Cx, inf-Cx and Med. The 
standard deviation in Table 2 represents the spread of mean 
values obtained. Table 3 shows the interobserver reproduc-
ibility for each ROI by sequence and participant group. For 
T1 and ADC, WK, Cx and rep-Cx were highly reproduc-
ible (ICC ≥ 0.76; CoV < 5%). For pCASL, Cx and rep-Cx 
were less readily reproducible (ICC > 0.86 but CoV up to 
14.2%). The reproducibility of Med ROI was excellent for 
T1, but less good for pCASL and ADC (Table 3). Table 4 
shows the spread of data within each ROI by reporting the 
mean ROI standard deviation as a proportion of the mean 
value. The spread of data from WK ROIs was higher than 
cortex-specific ROIs, even when the mean value for each 
was similar (Table 2).
Correlation between different ROIs
For T1, the correlation coefficient for Cx compared to WK, 
rep-Cx, sup-Cx, inf-Cx and Med was 0.76, 0.93, 0.86, 0.85 
and 0.62, respectively. The corresponding values for pCASL 
were 0.92, 0.91, 0.84, 0.81 and 0.26; and for ADC 0.87, 
0.79, 0.75, 0.85 and 0.78 [p < 0.001 for all, except pCASL 
Med which was not significant (p = 0.13)].
Comparison between participant groups
There was a significant difference in kidney volume between 
groups (F = 13.2, p < 0.001) with the greatest renal volume 
in Tx, then HF and then HV (Table 2). Mean T1 values also 
differed between participant groups (WK: F = 7.9, p = 0.001, 
Cx: F = 6.9, p = 0.003, rep-Cx: F = 7.1, p = 0.003). However, 
on paired comparisons, there was no difference in T1 results 
between HV and HF cohorts, while mean cortical T1 values 
were 122.4 ms (p = 0.009) and 84.7 ms (p = 0.02) greater 
in the Tx group compared to HV and HF groups, respec-
tively. Medullary T1 values were also higher in Tx than HV 
(mean difference 129.1 ms, p = 0.03). There were no dif-
ferences between groups on any cortical ROI for pCASL 
or ADC. Medullary pCASL values were significantly lower 
in Tx group compared to HV (mean difference − 35.7 ml/
min/100 g, p = 0.03) and HF (mean difference − 48.4 ml/
min/100 g, p = 0.03).
Table 1  Patient demographics 
and clinical characteristics
HV healthy volunteers, HF heart failure, Tx renal transplant, eGFR estimated glomerular filtration rate, IQR 
interquartile range
All (n = 40) HV (n = 10) HF (n = 10) Tx (n = 20)
Age (years), median (IQR) 56 (39–63) 43 (30–58) 62 (54–70) 51 (38–61)
Male (n, %) 28 (70%) 4 (40%) 7 (70%) 17 (85%)
eGFR (ml/min/1.73 m2), 
median (IQR)
60.0 (37.7–76.7) NA 77.1 (65.8–86.9) 48.4 (36.1–64.3)
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Table 2  Comparison of results 
depending on region of interest, 
MRI sequence and participant 
group
The standard deviation presented represents the spread of mean values. Volume measured by contouring 
alternate slices was similar to contouring every slice in all groups. Within each group, the values for whole 
kidney, cortical and medullary regions of interest were different for T1 and pCASL. In contrast, ADC val-
ues were similar for whole kidney, cortical and medullary regions of interest
HV healthy volunteers, HF heart failure, Tx renal transplant, SD standard deviation, rep-Cx area of repre-
sentative cortex, sup-Cx area of representative cortex at superior pole, inf-Cx area of cortex at inferior pole, 
Med medulla, pCASL pseudo-continuous arterial spin labelling, ADC apparent diffusion coefficient
All (n = 40) HV (n = 20) HF (n = 10) Tx (n = 10)
Mean SD Mean SD Mean SD Mean SD
Volume (ml) (n = 39)
Alternate slice 195.8 56.8 147.8 30.9 170.6 45.3 230.1 49.2
Every slice 197.5 57.4 149.0 31.3 170.8 44.9 232.6 49.3
T1 (ms) (n = 39)
Whole kidney 1772.8 131.4 1702.4 76.7 1696.5 85.7 1842.6 134.4
Cortex 1630.2 102.0 1557.7 104.1 1595.5 80.1 1680.1 86.3
rep-Cx 1606.1 114.4 1545.4 113.2 1543.8 71.1 1664.6 105.0
sup-Cx 1655.6 119.5 1606.8 149.8 1600.0 93.4 1705.3 98.1
inf-Cx 1639.0 103.7 1587.0 94.3 1590.0 113.3 1687.0 82.0
Med 1975.8 74.9 1899.0 80.5 1940.2 71.3 2028.1 74.2
Cortex: Med 0.83 0.82 0.82 0.83
pCASL (ml/min/100 g) (n = 37)
Whole kidney 181.7 56.6 187.5 58.4 161.6 47.1 190.2 60.7
Cortex 221.0 80.0 235.1 79.3 175.7 59.5 239.3 84.3
rep-Cx 260.8 91.4 271.8 93.5 228.4 92.3 273.3 90.4
sup-Cx 196.4 75.9 230.5 77.9 160.4 54.2 197.4 79.6
inf-Cx 225.2 105.2 213.8 91.1 161.8 84.4 269.2 107.5
Med 95.8 41.8 108.8 45.1 121.5 31.5 73.0 45.9
Cortex: Med 2.3 2.2 1.4 3.3
ADC (× 10−6 mm2/s) (n = 28)
Whole kidney 1687.6 115.6 1687.2 97.4 – – 1687.7 125.8
Cortex 1678.1 111.4 1704.0 96.8 – – 1665.8 118.1
rep-Cx 1696.9 117.7 1719.9 158.6 – – 1686.0 96.1
sup-Cx 1686.3 144.2 1720.4 120.6 – – 1670.1 154.5
inf-Cx 1696.4 115.2 1700.5 111.8 – – 1694.4 119.7
Med 1671.9 82.5 1726.3 93.9 – – 1646.1 77.2
Cortex: Med 1.0 1.0 1.0
Correlation between renal MRI and kidney function
eGFR data were available for the 30 participants with 
heart failure or a renal transplant. There was no correlation 
between eGFR and renal volume, T1 or pCASL. There was 
a positive correlation between eGFR and ADC (Tx group 
only), with coefficients of: WK 0.47 (p = 0.04), Cx 0.61 
(p = 0.006), rep-Cx 0.72 (p = 0.001), sup-Cx 0.45 (p = 0.05), 
inf-Cx 0.67 (p = 0.002) and Med 0.48 (p = 0.04).
Discussion
This study provides evidence to support the reproducibility 
of certain analysis techniques for renal MRI using commer-
cially available analysis software. This is an essential step to 
allow studies exploring the clinical significance of functional 
renal MRI to report in confidence. Our data show that meas-
urement of renal volume by contouring a localiser image is 
highly reproducible between observers. Contouring alternate 
slices, as opposed to every slice, results in a small reduction 
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in measured volume with the advantage of improved effi-
ciency. We believe the 1.6 ml (0.8%) mean difference, in 
volume by contouring alternate slices, is clinically insig-
nificant, but nevertheless we would advise consistency with 
whichever approach is chosen. Whilst automated contouring 
and volume calculation is being utilised by some centres 
[16] and is likely to improve time efficiency, this approach 
is still to be externally validated and widely available. For 
T1, pCASL and ADC, WK ROIs are highly reproducible 
and commonly reported, but the mean value is derived from 
an unduly wide range of values, as evidenced by the fact on 
average the ROI SD represented between 17 and 55% of the 
mean value in our cohort. We would argue this summary 
Fig. 2  Representative image 
(T1) displaying the regions of 
interest drawn for whole kidney 
(WK), cortex (Cx), representa-
tive cortex (rep-Cx), superior 
cortex (sup-Cx), inferior cortex 
(inf-Cx) and medulla (Med)
Fig. 3  Bland–Altman plot 
comparing kidney volume as 
measured by contouring alter-
nate slice versus every slice
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statistic is a crude representation of the physiological tissue, 
which we hope to describe and that cortical values may have 
more biological relevance, without unacceptable reduction 
in reproducibility. Indeed, for ADC, the correlation with 
renal function of cortical ROIs was stronger than for WK. 
When drawing a small ROI of representative cortex, pre-
specifying its location to be at either the superior (sup-Cx) or 
inferior (inf-Cx) pole did not improve reproducibility com-
pared to a user-defined location and reduced the correlation 
with total cortex (Cx) for T1 and pCASL. Furthermore, sup-
Cx and inf-Cx are theoretically more susceptible to artefact 
from respiratory movement in native kidneys compared to 
regions of lateral/medial cortex that would move in plane. 
We therefore advise that either Cx or rep-Cx be used prefer-
entially, whenever cortical values are reported. Drawing an 
ROI for rep-Cx is likely to reduce analysis time compared 
to whole cortex and in this small sample, the correlation 
between eGFR and ADC was greatest when rep-Cx was 
used. However, this is balanced against the lower ICC for 
rep-CX than Cx. Further studies are required to distinguish 
their benefits and we suggest that either Cx or rep-Cx can 
be used to report cortical values in the interim. Neverthe-
less, development of a harmonised approach across centres 
is vital to allow broader use of renal MRI in research and 
clinical settings [1].
While there was a significant correlation between ADC 
and eGFR, there was no association between renal volume, 
T1 and pCASL with renal function. Although this may gen-
erate scepticism with regards to the clinical relevance of 
these sequences, the development of MRI biomarkers is 
intended to provide physiologic and prognostic information 
Table 3  Interobserver reproducibility by MRI sequence and analysis 
approach
Whole kidney and cortical ROIs were highly reproducible in all 
sequences
CoV coefficient of variation, ICC intraclass correlation coefficient, 
rep-Cx area of representative cortex, sup-Cx area of representative 
cortex at superior pole, inf-Cx area of cortex at inferior pole, Med 
medulla, pCASL pseudo-continuous arterial spin labelling, ADC 
apparent diffusion coefficient
CoV (%) ICC
Volume (ml) (n = 39)
Alternate slice 6.5 0.97
Every slice 6.7 0.96
T1 (ms) (n = 39)
Whole kidney 1.0 0.97
Cortex 1.2 0.97
rep-Cx 2.0 0.95
sup-Cx 3.2 0.96
inf-Cx 2.5 0.86
Med 2.6 0.87
pCASL (ml/min/100 g) (n = 37)
Whole kidney 7.0 0.90
Cortex 10.3 0.93
rep-Cx 14.2 0.86
sup-Cx 19.1 0.69
inf-Cx 14.6 0.92
Med 29.6 0.73
ADC (× 10−6 mm2/s) (n = 28)
Whole kidney 2.0 0.90
Cortex 2.6 0.85
rep-Cx 3.7 0.76
sup-Cx 5.0 0.64
inf-Cx 3.8 0.62
Med 5.5 0.50
Table 4  Table representing the spread of data from which the mean is 
calculated depending on region of interest and MRI sequence
The ROI standard deviation is generated by the analysis software to 
represent the spread of values within each ROI. This table reports 
the mean ROI standard deviation for each sequence and displays it 
as a proportion of the mean value. The spread of data is larger for 
whole-kidney values, which includes cortical and medullary values as 
well as potential confounding data from vessels and renal pelvis. Con-
versely, the spread of data from the smaller ROIs of representative 
cortex may be uncharacteristically low if too small a ROI is drawn to 
be truly representative
ROI region of interest, SD standard deviation, rep-Cx area of repre-
sentative cortex, sup-Cx area of representative cortex at superior pole, 
inf-Cx area of cortex at inferior pole, Med medulla, pCASL pseudo-
continuous arterial spin labelling, ADC apparent diffusion coefficient
ROI SD (mean) ROI SD as propor-
tion of mean value 
(%)
T1 (ms) (n = 39)
Whole kidney 354.1 20.0
Cortex 125.7 7.7
rep-Cx 49.6 3.1
sup-Cx 71.4 4.3
inf-Cx 69.8 4.3
Med 74.9 3.8
pCASL (ml/100 g/min) (n = 37)
Whole kidney 100.7 55.4
Cortex 85.1 38.5
rep-Cx 41.2 15.8
sup-Cx 48.0 24.5
inf-Cx 53.2 23.6
Med 41.8 43.6
ADC (× 10−6 mm2/s) (n = 28)
Whole kidney 289.5 17.2
Cortex 169.6 10.1
rep-Cx 71.5 4.2
sup-Cx 105.8 6.3
inf-Cx 85.9 5.1
Med 84.7 5.1
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additional to existing clinical measures, but further studies 
are needed to clarify this.
We performed a limited comparison of medullary val-
ues. Future studies may wish to analyse the medulla in more 
detail. Recent studies have reported measures of corticome-
dullary differentiation (CMD) using T1 and ADC and their 
correlation with clinical parameters [17–19]. These studies 
were well-conducted, but there is a risk of over interpreting 
the significance of cortico-medullary findings. Loss of CMD 
is a well-established, non-specific finding in CKD that is 
detectable on ultrasound, computed tomography and MRI 
[20]. Any observed association between eGFR and CMD 
on T1 or ADC may underplay the utility of MRI as a func-
tional measurement and may instead detect a crude structural 
change that is prevalent in CKD, and which can be measured 
in simpler ways.
The study is strengthened by its multi-parametric 
protocol across both healthy and diseased populations, 
including native and transplant kidneys yielding clinically 
meaningful results. The study has a number of limitations. 
Whilst we have shown these analyses to be reproduc-
ible, the clinical significance of any approach is not yet 
established. We did not assess R2* [also known as blood-
oxygen-level-dependent (BOLD) imaging]. This param-
eter is recommended to be included in multi-parametric 
renal MRI protocols and its inclusion in this study would 
have been advantageous [1]. Only two observers reported 
each ROI for comparison of interobserver reproducibility. 
Kidney volume measurements were not compared with 
established 3D contrast-enhanced techniques, and further 
studies are required to assess the clinical relevance of 
kidney volume as measured by this approach. The cur-
rent pCASL sequences utilise a fixed T1 value. We accept 
there may be advantages of using a measured T1 and we 
are exploring this for future studies. Other centres have 
developed efficient and accurate analysis methods, often 
using in-house developed software, which we are unable to 
replicate. For instance, a technique that uses a histogram 
to numerically segregate cortical from medullary values 
has been reported [4]. These analysis strategies require 
bespoke software which generally relies upon precise har-
monisation of acquisition parameters to allow use out-with 
the centre in which they are developed. Nevertheless, com-
parison of results generated using this technique with the 
approaches detailed here would be interesting. The use of 
commercially available software in this study is strength. 
However, the license carries a cost and the software used 
is designed for cardiovascular analysis, such that we have 
applied many of the modules out-with their intended use. 
There is an urgent need for widely available software that 
is specifically designed for multi-parametric renal MRI 
analysis to advance the research and clinical application 
of renal MRI.
Conclusion
There are numerous strategies to analyse multi-parametric 
renal MRI with many centres using in-house bespoke soft-
ware. The optimal approach is not yet known. These results 
provide justification for one approach using commercially 
available software. We suggest that kidney volume can be 
calculated by contouring alternate slices, rather than every 
slice, of a localiser scan albeit validation with 3D volume 
techniques is still required. For T1, pCASL and ADC, we 
suggest that whole kidney values, while highly reproduc-
ible, are used with caution given that the results represent 
a central value from an extremely wide range. Instead, 
manually delineated cortex or a small ROI of user-defined 
representative cortex can be used interchangeably in both 
native and transplant kidneys, with acceptable interob-
server reproducibility. Clinical correlation of the results 
generated from this approach is eagerly awaited.
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